<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECT: Insulin has been shown to ameliorate cerebral <z:mp ids='MP_0001651'>necrosis</z:mp> in global and, more recently, in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The goal of this study was to determine the relationship between this neuroprotective effect and blood sugar levels in a rat model of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Thirty-four rats were subjected to 80 minutes of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> at a mean arterial blood pressure of 60 mm Hg and a temperature of 37 degrees C </plain></SENT>
<SENT sid="3" pm="."><plain>Insulin (3.5 IU/kg) was administered 1 hour before (12 rats) and 20 minutes after (12 rats) <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>; 10 animals served as controls </plain></SENT>
<SENT sid="4" pm="."><plain>A quantitative histopathological study conducted after 1 week of survival showed that insulin was not beneficial in reducing the size of the infarction or selective neuronal <z:mp ids='MP_0001651'>necrosis</z:mp> in the penumbra when administered before or after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In addition to infarction, six animals from the insulin-treated groups had bilateral selective neuronal <z:mp ids='MP_0001651'>necrosis</z:mp> in the hippocampus or the neocortex </plain></SENT>
<SENT sid="6" pm="."><plain>A nonlinear regression analysis in which <z:chebi fb="105" ids="17234">glucose</z:chebi> levels were compared with both cortical <z:mp ids='MP_0001651'>necrosis</z:mp> and total infarction yielded a U-shaped curve with a nadir for cerebral <z:mp ids='MP_0001651'>necrosis</z:mp> that lay in the 6- to 7-mM blood <z:chebi fb="105" ids="17234">glucose</z:chebi> range </plain></SENT>
<SENT sid="7" pm="."><plain>The increased brain damage induced by insulin occurred in animals with very <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">low blood sugar</z:e> values in the range of 2 to 3 mM </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: These results in rats indicate that if insulin is used following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels should be maintained at approximately 6 to 7 mM </plain></SENT>
<SENT sid="9" pm="."><plain>From these data one can infer that <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> of less than 3 mM should be avoided in situations of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in which insulin is used </plain></SENT>
<SENT sid="10" pm="."><plain>Additional animal studies and clinical trials in humans are needed to study the effects of insulin on <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>